- Home
- NMM vs BBNX Comparison
NMM vs BBNX Comparison
Compare NMM & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMM
- BBNX
- Stock Information
- Founded
- NMM 2007
- BBNX 2015
- Country
- NMM Greece
- BBNX United States
- Employees
- NMM N/A
- BBNX N/A
- Industry
- NMM Marine Transportation
- BBNX Medical/Dental Instruments
- Sector
- NMM Consumer Discretionary
- BBNX Health Care
- Exchange
- NMM Nasdaq
- BBNX Nasdaq
- Market Cap
- NMM 1.3B
- BBNX 1.2B
- IPO Year
- NMM 2007
- BBNX 2025
- Fundamental
- Price
- NMM $52.93
- BBNX $31.83
- Analyst Decision
- NMM
- BBNX Strong Buy
- Analyst Count
- NMM 0
- BBNX 11
- Target Price
- NMM N/A
- BBNX $28.09
- AVG Volume (30 Days)
- NMM 115.9K
- BBNX 723.4K
- Earning Date
- NMM 11-18-2025
- BBNX 10-28-2025
- Dividend Yield
- NMM 0.38%
- BBNX N/A
- EPS Growth
- NMM N/A
- BBNX N/A
- EPS
- NMM 8.94
- BBNX N/A
- Revenue
- NMM $1,311,114,000.00
- BBNX $88,570,000.00
- Revenue This Year
- NMM N/A
- BBNX $52.13
- Revenue Next Year
- NMM $9.93
- BBNX $36.07
- P/E Ratio
- NMM $5.85
- BBNX N/A
- Revenue Growth
- NMM N/A
- BBNX 67.01
- 52 Week Low
- NMM $28.37
- BBNX $8.89
- 52 Week High
- NMM $54.52
- BBNX $32.11
- Technical
- Relative Strength Index (RSI)
- NMM 68.27
- BBNX 72.33
- Support Level
- NMM $52.04
- BBNX $26.13
- Resistance Level
- NMM $54.12
- BBNX $29.22
- Average True Range (ATR)
- NMM 1.51
- BBNX 2.02
- MACD
- NMM 0.10
- BBNX 0.31
- Stochastic Oscillator
- NMM 69.00
- BBNX 98.18
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through the chartering of vessels and voyage contracts. Geographically, it generates majority revenue from Asia.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.